IL2103

N/A

Report date: 2024/08/21 14:44:23

Base Information

Drug NameIL2103
Drug Alias NameIL2103IL-2103
ClassificationOther
Mechanisms of ActionPoly (ADP-Ribose) polymerase degraders
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesiLeadBMS Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesiLeadBMS Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A